CI
BIIB icon

Chartist Inc’s Biogen BIIB Stock Holding History

Chartist Inc’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-907
Closed -$248K – 32
2017
Q1 		$248K Sell
907
-17
-2% -$4.81K 0.12% 29
2016
Q4 		$262K Sell
924
-63
-6% -$18.7K 0.13% 28
2016
Q3 		$309K Sell
987
-78
-7% -$23.1K 0.16% 24
2016
Q2 		$258K Buy
+1,065
New +$281K 0.14% 29
2015
Q4 		$347K Buy
+1,134
New +$326K 0.17% 24
2015
Q1 		– Sell
-9,605
Closed -$3.31M – 45
2014
Q4 		$3.31M Sell
9,605
-270
-3% -$87.3K 1.54% 20
2014
Q3 		$3.16M Sell
9,875
-86
-0.9% -$28.4K 1.65% 20
2014
Q2 		$3.17M Sell
9,961
-76
-0.8% -$22.9K 1.55% 20
2014
Q1 		$2.94M Sell
10,037
-94
-0.9% -$29.8K 1.57% 20
2013
Q4 		$2.82M Buy
+10,131
New +$2.62M 1.46% 19
2013
Q3 		– Sell
-10,468
Closed -$2.32M – 47
2013
Q2 		$2.32M Buy
+10,468
New +$2.24M 1.34% 20

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Chartist Inc's BIIB Position: Q2 2017 in Review

Chartist Inc sold out of Biogen (BIIB) in Q2 2017, closing a stake of 907 shares — an estimated $248K sold.

Chartist Inc first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $3.31M in Q4 2014. 993 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

  • Chartist Inc reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
  • Chartist Inc sold 907 Biogen shares in Q2 2017, an estimated $248K.
  • Chartist Inc first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
  • Chartist Inc's Biogen position peaked at $3.31M in Q4 2014.
  • 993 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Chartist Inc's 13F filing for Q2 2017, filed 15 Aug 2017.